RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Return
24.59%
This Quarter Return
+10.65%
1 Year Return
+24.59%
3 Year Return
+106.81%
5 Year Return
+195.15%
10 Year Return
+469.64%
AUM
$63.8B
AUM Growth
+$3.93B
(+6.6%)
Cap. Flow
-$997M
Cap. Flow
% of AUM
-1.56%
Top 10 Holdings %
Top 10 Hldgs %
22.75%
Holding
3,125
New
60
Increased
388
Reduced
2,522
Closed
139
Top Buys
| 1 |
Match Group
MTCH
|
+$20.9M |
| 2 |
Caesars Entertainment
CZR
|
+$14.2M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$12.6M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
+$12.2M |
| 5 |
PROG Holdings
PRG
|
+$11.8M |
Top Sells
| 1 |
Apple
AAPL
|
+$62.8M |
| 2 |
IAC Inc
IAC
|
+$23.5M |
| 3 |
CZR
Caesars Entertainment Corporation
CZR
|
+$19.1M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$15.7M |
| 5 |
Etsy
ETSY
|
+$15.6M |
Sector Composition
| 1 | Technology | 24.2% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 11.87% |
| 5 | Communication Services | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2376
GoHealth
GOCO
$75.9M
| $410K | ﹤0.01% |
+2,098
| New | +$410K |
|
|
LAND
2377
Gladstone Land Corp
LAND
$321M
| $410K | ﹤0.01% |
27,307
-3,850
| -12% | -$57.8K |
|
2378
Dime Community Bancshares
DCOM
$1.34B
| $409K | ﹤0.01% |
23,477
-5,800
| -20% | -$101K |
|
2379
Neurogene
NGNE
$265M
| $409K | ﹤0.01% |
1,702
-90
| -5% | -$21.6K |
|
2380
Forestar Group
FOR
$1.4B
| $408K | ﹤0.01% |
23,069
-4,736
| -17% | -$83.8K |
|
|
AKCA
2381
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $408K | ﹤0.01% |
22,512
-3,160
| -12% | -$57.3K |
|
2382
Mercantile Bank Corp
MBWM
$777M
| $406K | ﹤0.01% |
22,505
-8,104
| -26% | -$146K |
|
2383
Q32 Bio
QTTB
$21.7M
| $406K | ﹤0.01% |
2,106
-275
| -12% | -$53K |
|
|
ACCD
2384
DELISTED
Accolade, Inc. Common Stock
ACCD
| $406K | ﹤0.01% |
+10,443
| New | +$406K |
|
2385
Akero Therapeutics
AKRO
$3.46B
| $404K | ﹤0.01% |
13,130
+1,684
| +15% | +$51.8K |
|
2386
XPEL
XPEL
$990M
| $404K | ﹤0.01% |
15,477
-1,357
| -8% | -$35.4K |
|
2387
Phathom Pharmaceuticals
PHAT
$874M
| $400K | ﹤0.01% |
10,920
-1,870
| -15% | -$68.5K |
|
2388
Talos Energy
TALO
$1.72B
| $399K | ﹤0.01% |
61,881
+1,385
| +2% | +$8.93K |
|
2389
OneSpaWorld
OSW
$2.24B
| $398K | ﹤0.01% |
61,167
-10,591
| -15% | -$68.9K |
|
2390
UFP Technologies
UFPT
$1.55B
| $398K | ﹤0.01% |
9,611
-1,463
| -13% | -$60.6K |
|
2391
Gold Resource Corp
GORO
$106M
| $397K | ﹤0.01% |
116,526
-17,359
| -13% | -$59.1K |
|
2392
Scholar Rock
SRRK
$3B
| $397K | ﹤0.01% |
22,436
-3,935
| -15% | -$69.6K |
|
|
SYRS
2393
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $397K | ﹤0.01% |
4,489
-403
| -8% | -$35.6K |
|
2394
Annexon
ANNX
$252M
| $396K | ﹤0.01% |
+13,116
| New | +$396K |
|
2395
Zentalis Pharmaceuticals
ZNTL
$105M
| $396K | ﹤0.01% |
12,110
-1,031
| -8% | -$33.7K |
|
2396
Kiniksa Pharmaceuticals
KNSA
$2.68B
| $394K | ﹤0.01% |
25,706
+2,424
| +10% | +$37.2K |
|
2397
Lifecore Biomedical
LFCR
$262M
| $394K | ﹤0.01% |
40,552
-6,152
| -13% | -$59.8K |
|
2398
VSE Corp
VSEC
$3.45B
| $394K | ﹤0.01% |
12,868
-1,895
| -13% | -$58K |
|
2399
Financial Institutions
FISI
$548M
| $393K | ﹤0.01% |
25,549
-3,403
| -12% | -$52.3K |
|
2400
KALA BIO
KALA
$107M
| $393K | ﹤0.01% |
1,048
-161
| -13% | -$60.4K |
|